Entrepreneur Needed To Cure Anti-Initiative Disease

Originally published by Bruce Kasanoff on LinkedIn: Entrepreneur Needed To Cure Anti-Initiative Disease

AUTHOR'S NOTE: Seven days ago, I published this article on Forbes. It generated some of the most heartfelt, personal, and emotional comments I've ever received. I've included some of the below, so you can understand the urgency of supporting these people.

Perhaps 20 million people worldwide have had their lives curtailed by what I'm calling the Anti-Initiative disease. (In a moment, I'll tell you its more traditional names.)

This disease is horrific in that it literally punishes its victims when they display initiative. For example, if a patient who can't get out of bed for weeks then has a good day and decides to go sit in her backyard, she may then be dramatically worse for months.

A committee that studied this affliction suggested that it should be called "systemic exertion intolerance disease, or SEID... (because this) name captures a central characteristic of the disease: the fact that exertion of any sort— physical, cognitive or emotional—can adversely affect patients in many organ systems and in many aspects of their lives."

In other words, it punishes initiative of any sort.

Last week, I came face-to-face with the devastating nature of this disease when I attended a private FiRe Films Sundance screening - moderated by Managing Director Sharon Anderson Morris - of a new documentary, UNREST.

The film is a brave work of humanity by Jen Brea, who directed the documentary from her bed, because she has the disease. After the screening, Jen and her husband Omar Wasow joined us to explain that this disease affects perhaps 20 million people worldwide, yet is almost starved of funding to seek potential cures.

You can read more about Jen's work and her experiences in my original LinkedIn article.

Here are a few more sobering facts from the 2015 Institute of Medicine report I referenced above:

  • The disease affects 836,000 to 2.5 million Americans.

• An estimated 84 to 91% of people with it have not yet been diagnosed, meaning the true prevalence of this disease is unknown.

• At least one-quarter of patients are bed- or house-bound at some point in their illness.

• Symptoms can persist for years, and most patients never regain their pre-disease level of health or functioning.

• Patients experience loss of productivity and high medical costs that contribute to a total economic burden of $17 to $24 billion annually.

Professor Ron Davis is a renowned geneticist and director of Stanford’s Genome Technology Center; his son, Whitney, suffers from a particularly severe case of this disease. He believes - I'm paraphrasing here - that the disease may be a reaction by the human body to one of many different types of shocks, which could include a virus, severe injury, extremely high fever, or other "attack" that the body perceives and tries to protect itself from.